273 related articles for article (PubMed ID: 30278283)
1. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
[TBL] [Abstract][Full Text] [Related]
2. Role of the RUNX1-EVI1 fusion gene in leukemogenesis.
Maki K; Yamagata T; Mitani K
Cancer Sci; 2008 Oct; 99(10):1878-83. PubMed ID: 19016745
[TBL] [Abstract][Full Text] [Related]
3. Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos.
Maki K; Yamagata T; Asai T; Yamazaki I; Oda H; Hirai H; Mitani K
Blood; 2005 Sep; 106(6):2147-55. PubMed ID: 15914564
[TBL] [Abstract][Full Text] [Related]
4. A 5' untranslated region containing the IRES element in the Runx1 gene is required for angiogenesis, hematopoiesis and leukemogenesis in a knock-in mouse model.
Nagamachi A; Htun PW; Ma F; Miyazaki K; Yamasaki N; Kanno M; Inaba T; Honda Z; Okuda T; Oda H; Tsuji K; Honda H
Dev Biol; 2010 Sep; 345(2):226-36. PubMed ID: 20647008
[TBL] [Abstract][Full Text] [Related]
5. Fadd and Skp2 are possible downstream targets of RUNX1-EVI1.
Maki K; Sugita F; Nakamura Y; Sasaki K; Mitani K
Int J Hematol; 2013 Jan; 97(1):83-91. PubMed ID: 23250858
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
Nishikawa S; Arai S; Masamoto Y; Kagoya Y; Toya T; Watanabe-Okochi N; Kurokawa M
Blood; 2014 Dec; 124(24):3587-96. PubMed ID: 25298035
[TBL] [Abstract][Full Text] [Related]
8. RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks.
Kellaway SG; Keane P; Kennett E; Bonifer C
Haematologica; 2021 Jun; 106(6):1569-1580. PubMed ID: 32299907
[TBL] [Abstract][Full Text] [Related]
9. The role of EVI1 in normal and leukemic cells.
Buonamici S; Chakraborty S; Senyuk V; Nucifora G
Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
[TBL] [Abstract][Full Text] [Related]
10. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
[TBL] [Abstract][Full Text] [Related]
11. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
Tokita K; Maki K; Mitani K
Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
[TBL] [Abstract][Full Text] [Related]
12. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
[TBL] [Abstract][Full Text] [Related]
14. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
Sakai I; Tamura T; Narumi H; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
[TBL] [Abstract][Full Text] [Related]
15. RUNX1B Expression Is Highly Heterogeneous and Distinguishes Megakaryocytic and Erythroid Lineage Fate in Adult Mouse Hematopoiesis.
Draper JE; Sroczynska P; Tsoulaki O; Leong HS; Fadlullah MZ; Miller C; Kouskoff V; Lacaud G
PLoS Genet; 2016 Jan; 12(1):e1005814. PubMed ID: 26808730
[TBL] [Abstract][Full Text] [Related]
16. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
[TBL] [Abstract][Full Text] [Related]
17. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation.
Shimizu S; Nagasawa T; Katoh O; Komatsu N; Yokota J; Morishita K
Biochem Biophys Res Commun; 2002 Apr; 292(3):609-16. PubMed ID: 11922610
[TBL] [Abstract][Full Text] [Related]
18. MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.
Kohrs N; Kolodziej S; Kuvardina ON; Herglotz J; Yillah J; Herkt S; Piechatzek A; Salinas Riester G; Lingner T; Wichmann C; Bonig H; Seifried E; Platzbecker U; Medyouf H; Grez M; Lausen J
PLoS Genet; 2016 Mar; 12(3):e1005946. PubMed ID: 26990877
[TBL] [Abstract][Full Text] [Related]
19. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
20. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
